Search Articles

View query in Help articles search

Search Results (1 to 10 of 13 Results)

Download search results: END BibTex RIS


Modern Innovative Solutions to Improve Outcomes in Severe Asthma: Protocol for a Mixed Methods Observational Comparison of Clinical Outcomes in MISSION Versus Current Care Delivery

Modern Innovative Solutions to Improve Outcomes in Severe Asthma: Protocol for a Mixed Methods Observational Comparison of Clinical Outcomes in MISSION Versus Current Care Delivery

The primary objectives of this study are as follows: To assess whether asthma control (assessed by exacerbation history, Asthma Control Questionnaire (ACQ), health care utilization, and short-acting beta-agonist (SABA) usage) is improved in MISSION SAAC patients

Claire Roberts, Eleanor Lanning, Carole Fogg, Paul Bassett, Alison Hughes, Anoop J Chauhan

JMIR Res Protoc 2019;8(10):e9585


Digital Health Intervention for Asthma: Patient-Reported Value and Usability

Digital Health Intervention for Asthma: Patient-Reported Value and Usability

durability of their effects.Methods Digital Health Platform Participants were enrolled in a randomized controlled study to evaluate the impact of a Food and Drug Administration–cleared digital health platform on asthma outcomes including short-acting beta-agonist (SABA

Rajan Merchant, Rubina Inamdar, Kelly Henderson, Meredith Barrett, Jason G Su, Jesika Riley, David Van Sickle, David Stempel

JMIR Mhealth Uhealth 2018;6(6):e133


A Patient-Centered Mobile Health System That Supports Asthma Self-Management (breathe): Design, Development, and Utilization

A Patient-Centered Mobile Health System That Supports Asthma Self-Management (breathe): Design, Development, and Utilization

Merchant et al [33] demonstrated the effectiveness of the Propeller Health Asthma Platform at reducing the use of short-acting β-agonist (SABA) by 0.41 activations per day (vs 0.31 control), increasing the number of SABA-free days by 21% (vs 17% control).

Plinio Pelegrini Morita, Melanie S Yeung, Madonna Ferrone, Ann K Taite, Carole Madeley, Andrea Stevens Lavigne, Teresa To, M Diane Lougheed, Samir Gupta, Andrew G Day, Joseph A Cafazzo, Christopher Licskai

JMIR Mhealth Uhealth 2019;7(1):e10956


Evaluating the Validity of an Automated Device for Asthma Monitoring for Adolescents: Correlational Design

Evaluating the Validity of an Automated Device for Asthma Monitoring for Adolescents: Correlational Design

based on the 2007 NHLBI National Guidelines’ asthma control classification criteria involving 4 areas of asthma impairment, including the frequency of daily activity limitations, asthma symptoms, nighttime symptoms, and use of short-acting beta agonists (SABA

Hyekyun Rhee, Michael J Belyea, Mark Sterling, Mark F Bocko

J Med Internet Res 2015;17(10):e234